Keywords: GlaxoSmithKline, Pfizer, ViiV Healthcare, HIV/AIDS, R&D

ViiV Healthcare launches: a new specialist HIV company for GSK and Pfizer

Article | 04 November 2009

Print This

Confirming their intention first announced in the spring, to collaborate on HIV/AIDS, UK drug giant GlaxoSmithKline and USA-based behemoth ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in